| 产品名称： | Byssochlamys spectabilis (Udagawa et Suzuki) Houbraken et Samson |
|---|---|
| 商品货号： | TS165011 |
| Deposited As： | Paecilomyces variotii Bainier |
| Strain Designations： | MF5537 |
| Application： | produces sphingofungin E produces sphingofungin F |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 323: Malt agar medium ATCC® Medium 336: Potato dextrose agar (PDA) ATCC® Medium 343: V8 juice agar |
| Growth Conditions： | Temperature: 24°C to 26°C Atmosphere: Typical aerobic |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | Dung of cottontail rabbit, Sylvilagus floridanus, Santa Catalina Mountains, AZ |
| References： | Horn WS, et al. Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii. J. Antibiot. 45: 1692-1696, 1992. PubMed: 1474000 Kurtz MB, et al. Antibiotic eicosenoic acids. US Patent 5,233,062 dated Aug 3 1993 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Byssochlamys spectabilis (Udagawa et Suzuki) Houbraken et Samson |
|---|---|
| 商品货号： | TS165011 |
| Deposited As： | Paecilomyces variotii Bainier |
| Strain Designations： | MF5537 |
| Application： | produces sphingofungin E produces sphingofungin F |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 323: Malt agar medium ATCC® Medium 336: Potato dextrose agar (PDA) ATCC® Medium 343: V8 juice agar |
| Growth Conditions： | Temperature: 24°C to 26°C Atmosphere: Typical aerobic |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | Dung of cottontail rabbit, Sylvilagus floridanus, Santa Catalina Mountains, AZ |
| References： | Horn WS, et al. Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii. J. Antibiot. 45: 1692-1696, 1992. PubMed: 1474000 Kurtz MB, et al. Antibiotic eicosenoic acids. US Patent 5,233,062 dated Aug 3 1993 |
